Showing results (21-30 of 82) with videos related to
Sort By:
Pageof 9
Virology Journal|April 9, 2013
Comparison of polystyrene nanoparticles and UV-inactivated antigen-displaying adenovirus for vaccine delivery in miceLena Johrden, Matthias Tenbusch, Ruth Lietz, et al.Journal of Virology|September 25, 2009
Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virusRebekka Kohlmann, Sarah Schwannecke, Bettina Tippler, et al.Vaccines|January 18, 2020
Modulation of Vaccine-Induced HIV-1-Specific Immune Responses by Co-Electroporation of PD-L1 Encoding DNAPierre Tannig, Antonia Sophia Peter, Dennis Lapuente, et al.Retrovirology|October 26, 2013
GagPol-specific CD4⁺ T-cells increase the antibody response to Env by intrastructural helpGhulam Nabi, Michael Storcksdieck Genannt Bonsmann, Matthias Tenbusch, et al.Plos One|April 4, 2020
Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccineDennis Lapuente, Viktoria Stab, Michael Storcksdieck Genannt Bonsmann, et al.BMC Immunology|August 5, 2009
Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligandsClaudius Grossmann, Matthias Tenbusch, Godwin Nchinda, et al.Vaccines|October 6, 2020
Genetic Co-Administration of Soluble PD-1 Ectodomains Modifies Immune Responses against Influenza A Virus Induced by DNA VaccinationPierre Tannig, Antonia Sophia Peter, Dennis Lapuente, et al.Vaccine|June 10, 2008
Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virusVladimir V Temchura, Matthias Tenbusch, Godwin Nchinda, et al.Journal of Virology|November 18, 2011
Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infectionRuth Lietz, Wibke Bayer, Teona Ontikatze, et al.Vaccines|October 26, 2021
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty<sup>®</sup>)Jürgen Held, Jan Esse, Koray Tascilar, et al.Pageof 9